Jantomarna Therapeutics

Jantomarna Therapeutics is a biotechnology company providing computational design technology for protein-coding RNA therapeutics.

Its proprietary genetic algorithm optimises mRNA and related RNA sequences for efficacy, safety and manufacturability using mechanistic sequence-function models. The company offers contract sequence design, collaborative therapeutic development and access to its software through licensing or an API.

Its work includes vaccines, protein replacement and other investigational applications, with company-reported preclinical validation through research partnerships.